Emcure Pharma

Emcure Pharma, 43-Years Old Drugmaker Enters Dalal Street with 31% Premium

Emcure Pharma, 43-Years Old Drugmaker Enters Dalal Street with 31% Premium

BY Outlook Business Desk

Emcure Pharma IPO Receives 67.87 Times Subscription on Final Day of Offer

Emcure Pharma IPO Receives 67.87 Times Subscription on Final Day of Offer

BY PTI

Three Prominent Indian Businesswomen Among 20 Asian Lady Entrepreneurs In Forbes November Issue

BY Press Trust of India